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A B S T R A C T   
Endogenous steroid hormones and endocannabinoids (ECs) are important regulators in the stress response of the 
human body. For the measurement of chronic stress, hair analysis has been established as method of choice for 
long-term and retrospective determination of endogenous stress markers. A sensitive liquid chromatography- 
tandem mass spectrometry (LC-MS/MS) method for the quantification of five steroid hormones (cortisone, 
cortisol, androstenedione, testosterone, progesterone) and four endocannabinoids (anandamide, palmitoyle-
thanolamide, 2-arachidonylglycerol, oleoylethanolamide) in hair was developed and validated. The hair samples 
were extracted with methanol and cleaned up with a fully automated supported liquid extraction (SLE) before 
analysis. Special attention was paid to the difficulties accompanying the quantification of endogenous analytes in 
hair. 
Five different strategies for endogenous compound quantification in hair (surrogate analyte, standard addi-
tion, background correction, stripped matrix and solvent calibration) were tested and compared. As a result, the 
approach of the surrogate analyte was used for the quantification of steroid hormones whereas background 
correction was used for endocannabinoids. The measurement of 58 samples from healthy young adults allowed 
insights into endocannabinoid ranges in hair and the correlation to steroid hormones. No significant differences 
in steroid and EC concentration levels of male and female in hair were found, except for testosterone (p < 0.001) 
and androstenedione (p < 0.0001). Cortisol to cortisone and testosterone to androstenedione concentrations 
were significantly and positively correlated. There were significant intercorrelations between endocannabinoids.   
1. Introduction 
Steroid hormones and endocannabinoids (ECs) play an important 
role in the physiology and behavioral expression of the human stress 
response. The hormonal response to stress is activated along the 
hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis is regulated 
by cortisol and related steroids [1,2]. Over the short-term, activation of 
the HPA axis is helpful to cope with stressful events; over the long-term, 
a dysregulated HPA axis is associated with a wide range of negative 
effects on the body (e.g. depression, decreased immune system, hyper-
tension etc.) [3]. More and more studies indicate that the endocanna-
binoid system is an additional regulator of stress and the HPA axis [1]. 
The endocannabinoid system consists of receptors, enzymes and several 
endogenous ligands (endocannabinoids) binding to the cannabinoid 
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(CB) receptors, i.e. CB1 and CB2 [4]. The most investigated endo-
cannabinoids are N-arachidonylethanolamine (anandamide, AEA) and 
2-arachidonylglycerol (2-AG) which are known to be involved in affect, 
pain and stress regulation [5]. Other lipids that are associated with the 
EC system are palmitoylethanolamide (PEA) and oleoylethanolamide 
(OEA) which do not directly bind to the CB receptors but might modify 
AEA and 2-AG [6,7]. Most explanatory models are suggesting that 
cortisol and endocannabinoids are interlinked and that glucocorticoids 
induce fast feedback inhibition of the HPA axis [8]. 
Cortisol concentrations are highly fluctuating in plasma, saliva or 
urine underlying the circadian rhythm with usually highest concentra-
tions in the morning. The cortisol concentration in these classical 
matrices is depending on day time and other specific circumstances like 
food intake or alcohol consumption [9]. Keratinized matrices, such as 
hair, can reflect cumulative steroid levels over extended time periods 
(up to several months) [9]. In recent years, hair analysis has become an 
important tool for retrospective stress monitoring [3,10,11]. A number 
of studies have been performed in this field that investigated hair 
cortisol across a range of stress-related conditions in humans [12]. 
Increased hair cortisol has been shown to be associated with stressful 
conditions such as chronic pain [13], pregnancy [14], athletics [15] or 
alcoholism [16]. Research has also started to focus on the measurement 
of endocannabinoids as a biological regulator for stress [1]. It is known 
that also endocannabinoids like 2-AG underlie significant circadian 
changes and the concentration is changing during the day [17]. Because 
of the large number of physiological factors that can contribute to the 
changes of EC concentrations in body fluids, a reliable stress monitoring 
in blood, urine and saliva is challenging. Therefore, more and more 
studies use hair EC measurements for stress monitoring similar to hair 
cortisol. First studies revealed a correlation between endocannabinoids 
in hair and post-traumatic stress disorder symptoms (PTSD) [18], 
borderline personality disorder [19], childhood mistreatment [20], 
burnout, depression, anxiety symptoms [21] and obesity [22]. 
The analysis of endocannabinoids is an analytical challenge due to 
their low levels in biological matrices and their chemical similarity. First 
efforts for quantifying endocannabinoids were performed by gas 
chromatography-mass spectrometry (GC-MS) [23]. Nowadays, liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) is mainly used 
for the quantification of steroid hormones and ECs in biological matrices 
and the most common ionization techniques for the determination of 
endocannabinoids are electrospray ionization (ESI) and atmospheric 
pressure chemical ionization (APCI) [7,21,22,24]. Even though an 
increasing number of LC-MS/MS methods was developed to measure 
ECs in body fluids, poor agreement on sample collection, storage and 
preparation exists [25]. Also for the measurement of ECs in hair only a 
few publications exist to date [18–22]. For ECs, various pitfalls in the 
pre-analytics and analytics are known. The extraction should minimize 
contamination and isomerization. It was reported that several solvents 
can raise contamination of endocannabinoids and thus can be a chal-
lenge for the reliable detection of ECs [25]. Moreover, it is known that 
2-AG undergoes rapid isomerization to 1-AG whereas complete avoid-
ance seems to be impossible [7]. It is therefore important to extract the 
biological matrix in neutral solutions. The measurement of steroid 
hormones in hair, especially cortisol, is widely used and baseline values 
are defined whereas concentrations ranges for ECs are not established 
yet [26]. 
Endogenous compounds like steroids and ECs are more challenging 
to quantify and to validate than xenobiotic compounds. The FDA (Food 
and Drug Administration) states in its recommendation for method 
validation that the use of authentic matrix to spike with the analytes of 
interest is the best option [27]. For endogenous compounds, this is 
challenging, as there is commonly no authentic analyte-free matrix 
available. In some cases, analyte concentrations in the hair matrix are 
sufficiently low but this is rather rare. Several approaches have been 
described to overcome this problem like the use of standard addition, the 
use of surrogate matrix, the method of background correction or the use 
of surrogate analytes [28–30]. One possibility to obtain analyte-free 
matrix is to use a stripped matrix where endogenous compounds are 
actively removed from the hair or to use hair tips from long hair [28,29, 
31]. Hair tips can be used if the concentration of endogenous compounds 
is sufficiently low because of a general wash out effect [31]. Further-
more, the approach of surrogate analytes was applied successfully for 
the quantification of several steroid hormones in hair [32,33]. 
Overall, this study aimed to develop and validate an LC-MS/MS 
method for the simultaneous quantification of steroid hormones and 
endocannabinoids in hair. Special attention was paid to find a suitable 
quantification model for simultaneous determination of endogenous 
steroids and endocannabinoids in hair. Moreover, we applied the 
method to authentic hair samples to gain insights into endocannabinoid 
ranges in the hair matrix of healthy volunteers and to investigate the 
correlations to steroid hormones. 
2. Material and methods 
2.1. Chemical reagents 
Oleoylethanolamide, palmitoylethanolamide and deuterated inter-
nal standards (cortisone-D7, progesterone-D9) were purchased from 
Sigma Aldrich (Buchs, Switzerland). Anandamide, 2-arachidonylgly-
cerol and the deuterated internal standard (AEA-D11) were purchased 
from Cayman Chemicals (Ann Arbor, USA). 13C3-cortisol and 13C3- 
cortisone were purchased from Isoscience (Ambler, USA) and 13C3-an-
drostenedione, 13C3-testosterone and 13C3-progesterone from Sigma 
Aldrich (Buchs, Switzerland). Water and methanol were of LC–MS grade 
(Chromasolv®) and purchased from Sigma-Aldrich (Buchs SG, 
Switzerland). Acetone, ethyl acetate and ammonium fluoride were 
purchased from Merck (Darmstadt, Germany). Reconstitution solution 
consisted of 0.2 mM NH4F in water/methanol 97/3 v/v. Isolute® SLE +
columns were purchased from Biotage® (Uppsala, Sweden). All chem-
icals were of highest analytical grade. 
2.2. Preparation of standard stock solutions 
Final concentrations of 1 ng/μL of standards of each analyte were 
prepared in MeOH for the steroid hormones and in acetonitrile for the 
endocannabinoids. The internal standard mixture (cortisone-D7, pro-
gesterone-D9, AEA-D11) was prepared in acetonitrile at a final concen-
tration of 40 pg/μL for progesterone-D9 and AEA-D11 and 80 pg/μL for 
cortisone-D7. For calibration and validation experiments, stock solutions 
were prepared in different concentrations: 2, 20 and 200 pg/μL for 13C3- 
cortisol, 13C3-cortisone, 13C3-androstenedione, 13C3-testosterone and 
13C3-progesterone, 0.2, 2 and 20 pg/μL for AEA, 2, 20 and 200 pg/μL for 
2-AG and 200, 2.000 and 10.000 pg/μL for PEA and OEA. All stock so-
lutions were stored at −20 ◦C until use. 
2.3. Sample collection and ethical aspects 
For validation experiments, several different hair pools from healthy 
volunteers were prepared by snipping the hair and homogenizing it. For 
baseline values, authentic hair samples were measured from students 
that were recruited in the framework of a collaboration study (Jur-
STRESS, University of Regensburg, Germany). The present study was 
performed in full conformance with Swiss and German laws, particularly 
those pertaining to use of human materials in research. A statement of 
the Cantonal Ethics Board of the Canton of Zurich (document BASEC-Nr. 
Req-2017-00946) and the Ethics Board of the Faculty of Medicine of the 
University Regensburg, Germany (Nr. 14-101-0064) was obtained. Hair 
samples were collected from the posterior vertex region and cut as close 
to the scalp as possible. The 3 cm hair segment proximal to the scalp was 
analyzed. This segment represents the last three months prior to the 
sampling, based on an average hair growth rate of 1 cm/month. 
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2.4. Sample preparation and extraction 
Hair samples were segmented and washed for 3 min with 15 mL of 
deionized water, followed by washing for 2 min with 10 mL acetone. The 
Sarstedt tubes were shaken by hand during the washing process. The 
washing solutions were decanted and disposed. The samples were dried 
overnight at room temperature. After washing, the hair segments were 
cut into snippets. For extraction 20 mg hair sample was weighed in a 2 
mL Eppendorf tube and 50 μL internal standard (cortisone-D7, proges-
terone-D9, AEA-D11) and 1 mL methanol were added. The samples were 
briefly shaken and placed in a sonication bath (35 kHz, 600 W) for 4 h at 
55 ◦C for extraction. After centrifugation for 5 min at 9000 g, the 
methanolic extract was transferred into the column rack (24 × 6 mL) 
from Biotage® Extrahera (Biotage, Uppsala, Sweden). Sample extracts 
were automatically loaded onto Isolute SLE + columns and allowed to 
absorb for 5 min. Analytes were then eluted two times with 2.5 mL ethyl 
acetate with a wait time of 5 min in-between. The extracts were dried in 
a Turbovap® (Biotage, Uppsala, Sweden) and resuspended in 60 μL 
MeOH and 140 μL reconstitution solution. 
2.5. LC-MS/MS analysis 
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) 
device was used for the analysis of the sample extracts. Analytes were 
separated with a Prominence UFLC system (Shimadzu, Kyoto, Japan) by 
injecting 10 μL of the samples onto a Phenomenex® Kinetex® XB-C18 
(2.6 μm, 50 × 2.10 mm) column. The mobile phase consisted of 0.2 mM 
NH4F in water/methanol 97/3 v/v (A) and 0.2 mM NH4F in water/ 
methanol 3/97 v/v (B). The flow rate was 0.40 mL/min and the tem-
perature of the column oven was set to 40 ◦C. Separation was achieved 
by the following gradient: 0–40% B for 0–0.1 min, isocratic 40% from 
0.1 to 1 min, 40–70% B from 1 to 5 min, isocratic 70% for 5–6 min, 
70–80% from 6 to 7 min, isocratic 80% for 7–11 min, 80–90% from 11 to 
14 min, isocratic 99% B from 14.1 to 17 min, 99–40% B from 17 to 19 
min followed by an equilibration step of 1 min. Detection was performed 
with a QTRAP® 6500+ linear ion trap quadrupole mass spectrometer 
(Sciex®, Darmstadt, Germany) equipped with an electrospray ionization 
(ESI) source. Analytes were measured in positive ESI mode. Multiple 
reaction monitoring mode (MRM) with an ion spray voltage of 4500 V 
was used for quantification (see Table 1). The method parameters are 
listed in Table 1. The curtain gas was fixed at 20 psi, the collision gas was 
set to high, the ion source gas 1 at 70 psi and ion source gas 2 at 50 psi. 
The source temperature was set to 600 ◦C. Analyst® software (version 
1.6.3, Sciex®, Darmstadt, Germany) was used for instrument control 
and data analysis. 
2.6. Quantification model 
The hair matrix naturally contains individual endogenous concen-
trations of steroids and ECs. Therefore, it is challenging to find a true 
“blank” hair matrix for validation and calibration. Five different stra-
tegies were tested to circumvent the lack of blank matrix for the quan-
tification of the above-mentioned compounds. For the quantification of 
steroid hormones in hair, the surrogate analyte approach in adaption to 
our previous work was used [32–34]. 13C3-cortisol, 13C3-cortisone, 
13C3-androstenedione, 13C3-testosterone, and 13C3-progesterone were 
used for calibration of steroids. The end concentrations for calibration 
were 0, 1, 5, 10, 50, 100, 200 pg/mg for 13C3-cortisol 13C3-cortisone, 
13C3-androstenedione, 13C3-testosterone and 13C3-progesterone, 
respectively. 
For ECs, 13C3-labeled analogues were not commercially available 
which is why alternative approaches were tested, namely: standard 
addition, background correction, stripped matrix and solvent 
calibration. 
For standard addition, four different hair pools were divided into 
equal aliquots and spiked with EC standards with the following end 
Table 1 
MRM transitions and MS parameters for all analytes and the internal standards. For each substance, the most sensitive transition was used for quantitation (quantifier) 
and the second sensitive was used for confirmation (qualifier). RT = retention time, DP = declustering potential, EP = entrance potential, CE = collision energy, CXP =
cell exit potential.  
Analyte Q1 mass [Da] Q3 mass [Da] RT [min] DP [V] EP [V] CE [V] CXP [V] 
Cortisone 1 361.0 163.0 2.87 145 10 46 11 
Cortisone 2 361.0 121.1 2.87 145 10 46 11 
Cortison-D7 368.0 169.0 2.87 145 10 46 11 
Cortisone13C3 1 364.0 166.0 2.87 76 10 31 8 
Cortisone13C3 2 364.0 124.1 2.87 76 10 37 6 
Cortisol 1 363.0 121.0 3.20 145 10 46 11 
Cortisol 2 363.0 90.9 3.20 6 10 31 10 
Cortisol13C3 1 366.0 124.0 3.20 56 10 29 18 
Cortisol13C3 2 366.0 330.1 3.20 56 10 29 18 
Androstenedione 1 287.1 97.0 4.75 145 10 46 11 
Androstenedione 2 287.1 109.2 4.75 145 10 46 11 
Androstenedione13C3 1 290.1 100.2 4.75 61 10 31 16 
Androstenedione13C3 2 290.1 112.1 4.75 145 10 46 11 
Testosterone 1 289.1 97.0 5.14 145 10 46 11 
Testosterone 2 289.1 109.0 5.14 145 10 46 11 
Testosterone13C3 1 292.1 100.0 5.14 91 10 27 14 
Testosterone13C3 2 292.1 111.9 5.14 91 10 31 16 
Progesterone 1 315.1 97.0 6.30 145 10 46 11 
Progesterone 2 315.1 108.9 6.30 145 10 46 11 
Progesterone-D9 324.1 100.0 6.30 145 10 46 11 
Progesterone13C3 1 318.1 100.0 6.30 26 10 29 16 
Progesterone13C3 2 318.1 112.1 6.30 26 10 31 12 
AEA 1 348.2 287.1 9.75 26 10 13 10 
AEA 2 348.2 61.9 9.75 26 10 13 10 
AEA-D11 359.3 61.9 9.75 1 10 13 8 
PEA 1 300.1 62.1 10.16 36 10 13 16 
PEA 2 300.1 283.3 10.16 36 10 15 14 
2-AG/1-AG 1 379.0 287.1 10.20/10.50 21 10 17 14 
2-AG/1-AG 2 379.0 269.1 10.20/10.50 21 10 13 12 
OEA 1 326.2 62.1 10.81 150 10 13 6 
OEA 2 326.2 69.1 10.81 46 10 13 6  
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concentrations: 0, 0.5, 1, 2, 5, 10, 20 pg/mg for AEA, 0, 5, 10, 50, 100, 
500, 1.000 pg/mg for 2-AG, 0, 500, 1.000, 2.000, 4.000, 10.000, 15.000 
pg/mg for PEA and OEA (see Table S1 in the supplementary). A cali-
bration curve was determined and the concentration of each hair pool 
was then calculated from the negative x-intercept of the linear regres-
sion line. 
For background correction, 20 mg of one hair pool for each calibrator 
was spiked with six different concentrations (Table S1) and a standard 
addition was performed to determine the endogenous concentration of 
ECs. The calibrator concentrations were corrected by adding the 
endogenous concentrations of the ECs to the spiked concentration. This 
resulted in a corrected calibration curve, which was then used for further 
EC quantification in other hair samples. 
To generate analyte-free matrix (stripped matrix), 500 mg hair tips 
from one individual were extracted in 20 mL MeOH consecutively for 
seven days. The MeOH was exchanged every day. After drying, 20 mg of 
the stripped hair pool was spiked with different EC concentrations 
(Table S1) to obtain a calibration curve. 
For solvent calibration, different concentrations of standards 
(Table S2) were added to matrix-free solvent (MeOH) and mixed with 
reconstitution solution. The mix was directly injected, i.e. no hair matrix 
was added to the solutions. 
2.7. Method validation 
The validation was performed in accordance to the guidelines of the 
GTFCh appendix C for hair [35]. The following parameters were eval-
uated: response factor (for the surrogate analytes), linearity, limit of 
detection (LOD), limit of quantification (LOQ), accuracy, precision, 
matrix effect, recovery and robustness. 
For steroid hormones, validation parameters were tested using 13C3- 
labeled surrogate analytes as described before [32–34,36]. Firstly, the 
response factor was calculated by the ratio of the responses found for 
surrogate and authentic analyte. If the response factor was not 1 it was 
incorporated into the regression line of the calibration curve in order to 
get the correct result for the quantification of the endogenous analyte. 
For endocannabinoids, validation parameters were determined by 
background correction as described above. For the calibration curve, the 
endogenous amount of EC concentrations was mathematically added to 
the spiked calibrator concentration (in pg/mg) resulting in a corrected 
calibration curve. For accuracy and precision, the quality control (QC) 
end concentrations were calculated by subtracting the endogenous hair 
pool concentration from the calculated concentration. For matrix effect 
and recovery, the peak area of the endogenous background concentra-
tion in the hair pool was subtracted from the peak area of the measured 
concentration. 
In general, validation parameters for steroid hormones and ECs were 
calculated as follows: For linearity, six calibrators with increasing con-
centrations and an unspiked sample (zero sample) were prepared. The 
regression lines were calculated using a simple linear model with 1/x 
weighting for steroid hormones and no weighting for ECs. LOD and LOQ 
were calculated and determined applying signal-to-noise ratios of 3:1 
and 10:1, respectively. For accuracy and precision, duplicates of a hair 
pool with different end concentrations according to substance classes 
were prepared (Table S4 in the supplementary). The measurements were 
carried out on six consecutive days. The bias as well as the intra- and 
inter-day precision was calculated for each analyte. For matrix effect 
and recovery, five replicates from different individuals at two different 
concentration levels were analyzed (Table S5). For the matrix effect, the 
ratio of peak areas of spiked hair (A) to spiked solvent (B) at the same 
concentration was compared. (Matrix effect = (A/B) x 100). For re-
covery, the ratio of peak area of spiked matrix before (C) and after (D) 
extraction was compared. (Recovery = (C/D) x 100). For robustness, 12 
replicates of an authentic hair pool were analyzed and the mean value of 
detectable analytes plus the relative standard deviation was determined. 
2.8. Statistical analysis 
Statistical analysis was conducted with GraphPad Prism 7.0 
(GraphPad Software, San Diego, CA, USA). Shapiro Wilk normality test 
revealed that the data were not normally distributed. Paired samples 
were compared using Wilcoxon signed rank test and unpaired samples 
were compared using Mann-Whitney test. Correlation coefficients were 
calculated using Spearman correlation. P-values > 0.05 were considered 
as not statistically significant (ns); p < 0.05 (*) as significant; p < 0.01 
(**) as very significant; p < 0.001 (***) and p < 0.0001 (****) as 
extremely significant. 
3. Results and discussion 
3.1. LC-MS/MS method 
In hair, first methods have been established for the simultaneous 
quantification of cortisol, cortisone, AEA and 2-AG [22,24]. With this 
newly developed LC-MS/MS method, several improvements have been 
achieved. To the best of our knowledge, it is the first method for the 
simultaneous quantification of five steroid hormones and four endo-
cannabinoids in hair. Our method enables the combined determination 
of these endogenous compounds in one LC-MS/MS run. 
Cortisone, cortisol, androstenedione, testosterone, progesterone, 
anandamide, 2-arachidonylglycerol, oleoylethanolamide and palmitoy-
lethanolamide in hair could be detected (see Fig. 1). All peaks were well 
resolved and appeared as single peak. 2-AG and its isomer 1-AG were 
separated. In contrast to plasma, where it was shown that 1-AG and 2-AG 
levels can change over the duration of storage [37], the hair matrix is a 
solid fiber matrix where analyte concentrations are more stable. Most 
methods describe the determination of 2-AG by integrating both peaks 
[17,38]. Thus, the concentration of 2-AG in this method was always 
calculated as a sum of both peaks. 
Positive electrospray ionization (ESI) as well as atmospheric pressure 
chemical ionization (APCI) can be used for the detection of 2-AG and 
AEA. The current method was based on ESI positive mode. It was 
demonstrated that the ESI-based method could detect very low EC levels 
as well as steroid levels in the hair matrix. In contrast to a previously 
published paper [22], no improvement in sensitivity could be shown 
when using APCI mode for our method (data not shown). It is known 
that the ionization source is specific for every manufacturer, thus can 
lead to different ion source reactions resulting in varying sensitivity. 
The extraction of endocannabinoids is a crucial step in the sample 
treatment. The herein established extraction was using methanol fol-
lowed by an automated sample clean-up. Supported liquid extraction 
(SLE) is analogous to liquid-liquid extraction (LLE) but uses an inert 
support. The sample is absorbed on the inert support material and an 
organic solvent flows through the support. The final extract is dried 
afterwards and can then be used for further analysis. It was shown, that 
SLE clean-up allowed an efficient recovery of all analytes and decreased 
background noises. The automated clean-up on the Biotage® Extrahera 
allowed fast and efficient sample through-put. In comparison to previ-
ously published work about quantification of endocannabinoids in hair 
[19–22,24], the implemented methanolic extraction was much shorter 
(4 h). This allows a minimum exposure to plastic and glass surfaces 
which is a known source of contamination in endocannabinoid analysis 
[7]. 
3.2. Choice of quantification model 
Even though several approaches exist for the quantification of 
endogenous compounds, it remains a challenge to find the adequate 
approach for the analytes of interest. Especially in hair analysis, it is 
difficult to find blank matrix for quantification of endogenous com-
pounds and no suitable surrogate matrix is commercially available. For 
steroid hormones, the approach of using 13C3-labeled analogues was 
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successfully implemented in hair and nails in the recent years [32–34, 
36]. The use of the surrogate analytes allowed a reliable quantification 
of several steroid hormones especially in low concentration ranges. As 
this strategy has been proven to be elegant and reliable, it was also used 
in this study for the quantification of steroids. However, for ECs, no 
13C3-labeled analogues were commercially available. Thus, different 
approaches for the quantification of ECs were tested, because of the lack 
of true blank matrix for endocannabinoids in hair. In general, four 
different hair pools were tested and quantified with different calibration 
models. Firstly, standard addition was used to determine the endoge-
nous concentrations of endocannabinoids in each of the four hair pools. 
In forensic toxicology, standard addition can be used for the quantifi-
cation of xenobiotics in matrices like blood and urine. In hair analysis, 
the use of standard addition is often challenging and cannot be per-
formed because of the small sample amount available. Thus, other ap-
proaches (background correction, stripped matrix and solvent 
calibration) were tested and compared to the concentrations obtained by 
standard addition. The goal was to find an adequate calibration curve 
that reliably quantifies the concentrations of endocannabinoids in each 
hair sample without the need to generate a standard addition for each 
sample. The difference of the concentrations compared to standard 
addition was calculated in percent (Table 2). The background correction 
showed reliable results for all four endocannabinoids in a range of -6.5% 
to 13.2% difference. The background correction has the advantage that 
the calibration curve is generated in authentic matrix and can then be 
used for the quantification of different samples. It still has to be taken 
into account that the hair pool used for the calibration curve can still 
contain low levels of endocannabinoids. If different batches of a pool are 
used, different background levels have to be corrected which can lead to 
deviations in concentrations. Thus, it can become difficult to find an 
optimal matrix for the calibration curve. The stripped matrix showed 
good results for some of the endocannabinoids (2-AG, AEA) but for PEA 
and OEA it showed high differences in the determined concentration 
(45.1%/-45.0%) compared to the standard addition. That can be 
explained by high endogenous amounts of PEA and OEA in authentic 
hair. Therefore, it was not possible to remove these substances fully out 
of the hair matrix. Furthermore, stripping the hair matrix can change the 
hair structure and lead to different matrix effects and extraction recov-
ery than in the original matrix. Another possibility of a surrogate matrix 
is the use of neat solvent for the preparation of the calibration curve. If 
solvent is used as a matrix, it has to be shown that the extraction re-
covery and matrix effects are similar to the original matrix. The differ-
ences compared to the standard addition were high for all 
endocannabinoids when using solvent calibration (−95.7% to 99.9%), 
indicating that solvent calibration is not suitable for quantification of 
ECs in hair. In our opinion, this can be attributed to the fact that hair is a 
solid matrix, which differs structurally from liquid matrices. For other 
applications, it was shown that solvent calibration was an adequate 
method for the quantification of xenobiotics in various body tissues and 
body fluids [39]. 
In conclusion, the comparison of these different methods clarified 
that it is important to use authentic hair matrix for the quantification of 
endogenous compounds and that surrogate matrices (stripped matrix, 
solvent) were not an adequate approach for the quantification of 
endocannabinoids in hair. For validation and quantification of authentic 
samples, the approach of background correction was used. 
3.3. Validation 
The validation parameters were determined with help of surrogate 
analytes for the steroid hormones and with background correction for 
the ECs and are provided in the supplementary. 
LOD, LOQ and correlation coefficient are displayed in Table S3 in the 
supplementary. Linearity was acceptable for all analytes with a corre-
lation coefficient of more than 0.99. For the surrogate analytes, the 
response factor was determined and integrated into the regression line 
(Table S3). The LODs for AEA (0.3 pg/mg) and 2-AG (1 pg/mg) were in 
similar range compared to previous published methods [21,22]. The 
Fig. 1. Chromatogram of the analytes measured by LC-MS/MS in MRM positive mode. 1 = cortisone, 2 = cortisol, 3 = androstenedione, 4 = testosterone, 5 =
progesterone, 6 = AEA, 7a = 2-AG/1-AG, 8 = PEA, 7b = 2-AG/1-AG, 9 = OEA. 
Table 2 
Comparison of the concentration difference of endocannabinoids compared to 
standard addition in percent. The concentrations were firstly calculated by 
standard addition and then compared to concentrations determined with 
background correction, a calibration in stripped matrix and solvent calibration. 
Results are shown as mean difference and standard deviation.  






AEA −4.3 ± 19.3 1.6 ± 27.7 −95.7 ± 3.4 
PEA 12.6 ± 4.8 45.1 ± 14.3 99.9 ± 32.7 
2-AG/1- 
AG 
−6.5 ± 4.3 −3.2 ± 4.1 −39.4 ± 4.6 
OEA 13.2 ± 10.1 −45.0 ± 13.3 97.8 ± 35.6  
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LOD for the steroid hormones was 0.1 pg/mg or below. For OEA and 
PEA, the LOD could not be determined because of the high endogenous 
concentration in hair. 
Accuracy was in a range of −15.9% up to 14.2% for all analytes 
(Table S4 in the supplementary). Intra-day precision (RSDr) was 20% or 
less for all analytes. All the inter-day values (RSDT) were less than 23%. 
The variability was generally higher for samples at low concentration. 
An explanation for this could be that the amount of spiked analyte is 
relatively low as compared to the endogenous level resulting in a higher 
variability. 
Recovery was over 80% for all analytes, which is acceptable 
considering the complexity of the matrix. For the matrix effect, the 
difference of peak areas of spiked hair extract compared to spiked sol-
vent should be similar. For some of the analytes ion suppression or ion 
enhancement occurred, thus the delta area was either lower or higher 
(Table S5 in the supplementary). 
To demonstrate the robustness of the method, an authentic hair pool 
was measured 12 times over a time period of one week. The mean 
concentration was 29.8 pg/mg (RSD, 9.8%) for cortisone, 6.2 pg/mg 
(RSD, 11.1%) for cortisol, 0.9 pg/mg (RSD, 15.9%) for androstenedione, 
0.9 pg/mg (RSD, 20.3%) for testosterone, 1.2 pg/mg (RSD, 14.0%) for 
progesterone, 1283 pg/mg (RSD, 10.4%) for PEA, 22.2 pg/mg (RSD, 
15.2%) for 2-AG, 740 pg/mg (RSD, 9.2%) for OEA. AEA was not 
detectable in the authentic hair pool. These data prove the robustness 
and precision of the analytical method. 
In conclusion, the validation proved that the combined strategy of 
surrogate analyte and background correction could be used for the 
determination of low endogenous levels of steroid hormones and ECs in 
hair. 
3.4. Analysis of authentic hair samples 
LC-MS/MS analysis was performed on 58 hair samples (20 males/38 
females, mean age: 23, age range: 21–31) from healthy young adults. 
The mean concentrations determined in the proximal segment of 3 cm 
length were 12.2 pg/mg for cortisone, 3.6 pg/mg for cortisol, 1.6 pg/mg 
for androstenedione, 0.7 pg/mg for testosterone, 2.9 pg/mg for pro-
gesterone, 1.9 pg/mg for AEA, 6046 pg/mg for PEA, 113 pg/mg for 2- 
AG/1-AG and 7006 pg/mg for OEA (Table 3). These ranges were in 
accordance with previously reported values of steroid hormones and 
endocannabinoids in hair [20,21,24]. 
Males showed significantly higher testosterone (p < 0.001) and an-
drostenedione (p < 0.0001) concentrations than females. For the other 
steroids (cortisone, cortisol, progesterone) and ECs, no significant dif-
ferences in concentration levels in hair of male and female were found. 
Previous literature described gender-dependent concentration ranges 
for steroid hormones and ECs [11,22,26,40]. Higher testosterone levels 
in males are probably due to the production of this hormone mainly in 
the testes in males [41]. 
From our data, correlations for steroid hormones and 
endocannabinoids were calculated. AEA showed a significant, positive 
correlation with 2-AG (r = 0.41, p < 0.01), OEA (r = 0.36, p < 0.01) and 
PEA (r = 0.31, p < 0.05). 2-AG was also significantly and positively 
correlated with OEA (r = 0.46, p < 0.001) and PEA (r = 0.34, p < 0.01). 
OEA and PEA had a strong positive correlation (r = 0.92, p < 0.0001). A 
positive correlation was found between cortisol and cortisone (r = 0.35, 
p < 0.01) and testosterone and androstenedione (r = 0.75, p < 0.0001). 
The correlation between cortisol and cortisone concentrations in hair 
has been described before [42]. Androstenedione is converted to 
testosterone via 17β-hydroxysteroid dehydrogenase and thus also re-
flects an indirect measurement of the enzyme activity [43]. The results 
showed that increased AEA concentrations are associated with higher 
2-AG levels, which is in accordance with previous results [22]. No sig-
nificant correlation was found between endocannabinoids and steroids. 
There are literature examples that describe a correlation of endo-
cannabinoids and steroids in plasma and serum. A study by Hill et al. 
examined the influence of EC levels in individuals with PTSD [44]. In 
this study, different correlation analyses were performed to assess 
plasma associations among ECs as well as the relationship to cortisol. No 
significant relationship of 2-AG to AEA, PEA and OEA was found 
whereas AEA, PEA and OEA did show intercorrelations with each other. 
The results were similar in the control group as well in the PTSD group. 
Furthermore, they could show that cortisol correlated with OEA, PEA 
and AEA, which they concluded indicates a positive association of ECs 
with circulating cortisol. However, no correlation was found for cortisol 
and 2-AG [44]. Another study found no correlation between AEA levels 
and progesterone in pre- and postmenopausal women [45]. In saliva, 
cortisol and 2-AG levels were negatively correlated [46]. 
For the hair matrix, literature provides examples of both the presence 
and absence of correlations between steroids and ECs [19,21,22,24]. 
The newest literature by Gao et al. found positive intercorrelations be-
tween OEA, PEA and SEA [21]. This is in accordance with our results. 
Mwanza et al. found a positive correlation between 2-AG and AEA as 
well as a positive correlation of 2-AG with cortisol and cortisone [22], 
whereas Krumbholz et al. described a negative correlation between ECs 
and glucocorticoids [24]. Wingenfeld et al. reported no significant cor-
relation between 1-AG/2-AG as well as no correlation between cortisol 
and AEA and cortisol [19]. These studies show that contradicting liter-
ature exists and depending on the matrix as well as the study cohort, 
different or no correlations are found between steroids and endo-
cannabinoids. The discrepancy of the results could be attributed to the 
different study conditions that were investigated in these studies and 
shows the complexity of the stress system and the need for further 
research in this field. 
Since changes in endocannabinoid levels are known to be of limited 
duration [47], it is also unclear if small changes in the EC concentrations 
following a stress response can be detected in hair. The window of 
detection for the hair matrix is several weeks up to several month, thus 
reflecting long-term cumulative effects. Temporary fluctuations that are 
quickly regulated in blood might not be detected using hair as matrix. 
Furthermore, substances can be incorporated into the hair matrix via 
different pathways, e.g. through blood, sebum or sweat. Therefore, 
blood correlations might also be reflected in the hair matrix but sebum 
and sweat effects could influence the levels of steroids and endocanna-
binoids, making interpretation challenging. More studies on larger co-
horts could help to understand the interactions between 
endocannabinoids, glucocorticoids and the HPA axis in more detail. 
This study was a first attempt to investigate endocannabinoid levels 
of healthy volunteers in the hair matrix. For a better comparison of 
endocannabinoid levels, establishment of normative baseline concen-
trations for ECs could be very useful. Furthermore, studies on the in-
fluence of hair color, washing behavior and age should be carried out. 
4. Conclusion 
An LC-MS/MS method that enables the simultaneous quantification 
Table 3 
Mean, median, 1st, and 3rd quartile concentrations (pg/mg) of steroids and 







1st and 3rd 
quartile (pg/ 
mg) 
Cortisone 12.2 11 7.9; 13.9 
Cortisol 3.6 2.1 1.4; 4.0 
Androstenedione 1.6 1.5 0.7; 2.3 
Testosterone 0.7 0.6 0.2; 2.7 
Progesterone 2.9 1.6 0.8; 2.9 
AEA 1.9 1.7 1.4; 2.4 
PEA 6046 4387 3083; 6281 
2-AG/1-AG 113 109 75.1; 145 
OEA 7006 4312 2492; 6799  
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of five steroid hormones and four endocannabinoids in the hair matrix 
was successfully developed and validated. Special emphasis was placed 
on an accurate quantification of these endogenous compounds. A com-
bination of surrogate analytes and background correction resulted in a 
reliable quantification at low pg/mg levels. A first proof-of-concept 
study with hair samples of 58 individuals showed that cortisone, 
cortisol, androstenedione, progesterone, testosterone, AEA, PEA, 2-AG 
and OEA could be detected in the hair matrix. Significant differences 
in concentrations in female and males were found for testosterone and 
androstenedione. The results indicated that endocannabinoid concen-
trations in hair showed strong correlations with each other as well as 
cortisol with cortisone. The data presented show the potential of the 
long-term retrospective measurement of endogenous biomarkers in hair. 
Future studies with larger cohorts could help to define age-, sex-, and 
color-dependent value ranges for steroids and endocannabinoids. 
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